Colchicine effects on Major Adverse Cardiac Events in patients who underwent PCI
Phase 3
Recruiting
- Conditions
- ST-elevation myocardial infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20230801059005N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 204
Inclusion Criteria
Patients who had experienced ST-elevation myocardial infarction (STEMI)
In angiography of patients, in at least one of the epicardial arteries larger than or equal to two and a half millimeters, there should be a stenosis equal to or greater than fifty percent, which has been managed through percutaneous coronary intervention and medical therapy.
patients were undergoing percutaneous coronary intervention (PCI).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiac events. Timepoint: at the beginning- 3 month- 6month. Method of measurement: questionnaire- angiography.
- Secondary Outcome Measures
Name Time Method Myocardial infarctions, chest pain, resuscitated cardiac arrests, cardiovascular-related deaths, and strokes. Timepoint: at the beginning- 3 month- 6 month. Method of measurement: medical records- questionnaire.